tiprankstipranks
FALCO HOLDINGS Co., Ltd (JP:4671)
:4671
Japanese Market

FALCO HOLDINGS Co., Ltd (4671) AI Stock Analysis

0 Followers

Top Page

JP:4671

FALCO HOLDINGS Co., Ltd

(4671)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
¥2,808.00
▲(4.74% Upside)
Action:DowngradedDate:03/24/26
The score is driven primarily by solid financial resilience (notably a low-leverage balance sheet) offset by multi-year revenue decline, margin compression, and inconsistent cash-flow conversion. Valuation is a key positive (low P/E and high dividend yield), while technical indicators remain weak and weigh on near-term outlook.
Positive Factors
Low leverage balance sheet
Very low debt levels and a conservatively financed balance sheet provide durable financial flexibility. This reduces solvency risk in downturns, preserves optionality for M&A or capex, and supports dividends and operating continuity even if revenues remain pressured.
Negative Factors
Multi-year revenue decline
Sustained top-line contraction over multiple years weakens operating leverage and erodes scale advantages in diagnostics. Continued revenue declines force margin trade-offs, limit reinvestment capacity, and could require strategic shifts to restore growth over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage balance sheet
Very low debt levels and a conservatively financed balance sheet provide durable financial flexibility. This reduces solvency risk in downturns, preserves optionality for M&A or capex, and supports dividends and operating continuity even if revenues remain pressured.
Read all positive factors

FALCO HOLDINGS Co., Ltd (4671) vs. iShares MSCI Japan ETF (EWJ)

FALCO HOLDINGS Co., Ltd Business Overview & Revenue Model

Company Description
FALCO HOLDINGS Co., Ltd., a medical service company, primarily provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. It offers clinical testing services in the fields of genetic tests, biochemis...
How the Company Makes Money
null...

FALCO HOLDINGS Co., Ltd Financial Statement Overview

Summary
Strong balance sheet with very low leverage supports resilience, but operating performance has weakened: revenue has declined for three straight years and margins have compressed materially versus 2022. Cash flow is consistently positive but volatile, with a notable free-cash-flow step-down in 2025 and uneven cash conversion.
Income Statement
62
Positive
Balance Sheet
82
Very Positive
Cash Flow
55
Neutral
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue43.52B43.31B43.01B46.91B50.01B43.61B
Gross Profit13.57B13.35B12.92B14.64B17.32B13.70B
EBITDA3.83B3.72B3.56B4.75B6.55B3.88B
Net Income1.98B1.92B1.67B2.26B3.53B1.85B
Balance Sheet
Total Assets36.75B36.02B36.42B38.89B40.26B37.07B
Cash, Cash Equivalents and Short-Term Investments9.32B9.42B10.06B12.60B10.64B11.62B
Total Debt1.24B1.44B817.00M2.80B4.07B5.90B
Total Liabilities12.21B10.76B10.40B12.30B16.77B16.58B
Stockholders Equity24.54B25.25B26.03B26.59B23.48B20.48B
Cash Flow
Free Cash Flow0.001.54B2.19B708.00M1.94B1.32B
Operating Cash Flow0.002.62B3.43B2.09B4.13B2.94B
Investing Cash Flow0.00-1.18B-1.45B322.00M-2.69B-52.00M
Financing Cash Flow0.00-2.08B-4.53B-448.00M-2.41B1.46B

FALCO HOLDINGS Co., Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2681.00
Price Trends
50DMA
2614.42
Positive
100DMA
2586.47
Positive
200DMA
2466.87
Positive
Market Momentum
MACD
8.22
Negative
RSI
58.09
Neutral
STOCH
53.53
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4671, the sentiment is Positive. The current price of 2681 is above the 20-day moving average (MA) of 2597.77, above the 50-day MA of 2614.42, and above the 200-day MA of 2466.87, indicating a bullish trend. The MACD of 8.22 indicates Negative momentum. The RSI at 58.09 is Neutral, neither overbought nor oversold. The STOCH value of 53.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4671.

FALCO HOLDINGS Co., Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥152.02B15.475.94%3.34%5.90%16.30%
74
Outperform
¥63.95B14.392.79%28.06%19.48%
67
Neutral
¥26.07B11.054.81%1.23%9.96%
60
Neutral
¥20.62B5.793.71%7.50%-281.41%
54
Neutral
¥20.74B87.609.87%-24.41%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
47
Neutral
¥22.99B-4.22-184.71%56.75%-97.56%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4671
FALCO HOLDINGS Co., Ltd
2,652.00
572.95
27.56%
JP:4563
AnGes
58.00
-2.00
-3.33%
JP:4694
BML
4,065.00
1,379.60
51.37%
JP:2395
Shin Nippon Biomedical Laboratories, Ltd.
1,536.00
288.98
23.17%
JP:4538
Fuso Pharmaceutical Industries,Ltd.
2,350.00
338.99
16.86%
JP:4579
RaQualia Pharma Inc.
848.00
537.00
172.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026